Biohaven
- Market cap
- 1.79B
- P/E (TTM)i
- -2.61
- P/Bi
- 146.67
- EPSi
- -6.86
- Div yieldi
- 0.00%
- 52W posi
- 40%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Biohaven closed at 11.88, down 1.66%. At current prices, the business is worth about 1.79B, the #2805 most valuable US-listed company we track. The 10 analysts covering the stock are, on balance, at Buy, targeting an average of 21.00 (+77%). Against a 52-week band of 7.48-18.57, the shares are currently 40% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 2 days.
- Its last 3 Sell calls were followed by roughly flat moves (-2%) three months out.
- Recent price momentum is -22.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 13.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 12.08
- Open
- 11.86
- Day range
- 11.85 - 12.23
- Avg price
- 11.96
- Volume
- 2.15M
- Turnover
- 25.68M
- Turnover ratei
- 1.84%
- Volume ratioi
- 1.14
- Amplitudei
- 3.20%
- 52-week rangei
- 7.48 - 18.57
Valuation
- P/Ei
- -1.73
- P/E (TTM)i
- -2.61
- P/Bi
- 146.67
- EPSi
- -6.86
- Book value / shi
- 0.08
- Net profit
- -1.04B
- Net assets
- 12.23M
Share structure
- Market cap
- 1.79B
- Float capi
- 1.38B
- Shares out
- 151.04M
- Float sharesi
- 116.57M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2017-05-04
36.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-7.46M net over the window
Short interest
- Shares short
- 20.45M
- % of floati
- 13.54%
- Days to coveri
- 6.52
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Biohaven (BHVN)?
Biohaven last traded at 11.88. The quote on this page refreshes every few seconds while US markets are open.
What is Biohaven's market cap?
About 1.79B.
What is the P/E ratio of Biohaven?
The trailing twelve-month P/E is -2.61. The Valuation tab shows it against the stock's own five-year range.
Does Biohaven pay a dividend?
Biohaven does not currently pay a regular dividend.
Is Biohaven a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 21.00, which implies 76.8% upside from the current price. This is not investment advice.
What is Biohaven's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Biohaven a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-10-08 08:18:49 · For reference only, not investment advice and not tailored to your situation.